{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T21:46:33Z","timestamp":1696369593840},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/nrurol.2010.1","type":"journal-article","created":{"date-parts":[[2010,2,10]],"date-time":"2010-02-10T09:20:55Z","timestamp":1265793655000},"page":"66-68","source":"Crossref","is-referenced-by-count":2,"title":["Combining antimuscarinics shows promise for overactive bladder"],"prefix":"10.1038","volume":"7","author":[{"given":"Jean-Jacques","family":"Wyndaele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrurol20101_CR1","first-page":"793","volume-title":"Incontinence","author":"JJ Wyndaele","year":"2009","unstructured":"Wyndaele, J. J.  et al. in Incontinence (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A.) 793\u2013960 (Health Publication, Paris, 2009)."},{"key":"BFnrurol20101_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/med.20158","volume":"29","author":"I Peretto","year":"2009","unstructured":"Peretto, I., Petrillo, P. & Imbimbo, B. P. Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists. Med. Res. Rev. 29, 867\u2013902 (2009).","journal-title":"Med. Res. Rev."},{"key":"BFnrurol20101_CR3","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.juro.2009.05.099","volume":"182","author":"S Bolduc","year":"2009","unstructured":"Bolduc, S., Moore, K., Lebel, S., Lamontagne, P. & Hamel, M. Double anticholinergic therapy for refractory overactive bladder. J. Urol. 182, 2033\u20132038 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol20101_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0079-6123(05)52009-0","volume":"152","author":"LA Birder","year":"2006","unstructured":"Birder, L. A. Role of the urothelium in urinary bladder dysfunction following spinal cord injury. Prog. Brain Res. 152, 135\u2013146 (2006).","journal-title":"Prog. Brain Res."},{"key":"BFnrurol20101_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1474-8673.2002.00258.x","volume":"22","author":"R Chess-Williams","year":"2002","unstructured":"Chess-Williams, R. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton. Autacoid. Pharmacol. 22, 133\u2013145 (2002).","journal-title":"Auton. Autacoid. Pharmacol."},{"key":"BFnrurol20101_CR6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/j.1464-410X.2009.08380.x","volume":"103","author":"HT Liu","year":"2009","unstructured":"Liu, H. T., Chancellor, M. B. & Kuo, H. C. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int. 103, 1668\u20131672 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol20101_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/nau.20289","volume":"25","author":"M Horstmann","year":"2006","unstructured":"Horstmann, M., Schaefer, T., Aguilar, Y., Stenzl, A. & Sievert, K. D. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol. Urodyn. 25, 441\u2013445 (2006).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol20101_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.eururo.2008.06.032","volume":"55","author":"CG Roehrborn","year":"2009","unstructured":"Roehrborn, C. G.  et al. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur. Urol. 55, 472\u2013479 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol20101_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.juro.2009.05.038","volume":"182","author":"AP Cameron","year":"2009","unstructured":"Cameron, A. P., Clemens, J. Q., Latini, J. M. & McGuire, E. J. Combination drug therapy improves compliance of the neurogenic bladder. J. Urol. 182, 1062\u20131067 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol20101_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.eururo.2008.01.007","volume":"53","author":"B Amend","year":"2008","unstructured":"Amend, B.  et al. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur. Urol. 53, 1021\u20131028 (2008).","journal-title":"Eur. Urol."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:45:16Z","timestamp":1684471516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2010.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFnrurol20101"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2010.1","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}